Literature DB >> 30403147

Metabolism and Redox in Pulmonary Vascular Physiology and Pathophysiology.

Norah Alruwaili1, Sharath Kandhi1, Dong Sun1, Michael S Wolin1.   

Abstract

Significance: This review considers how some systems controlling pulmonary vascular function are potentially regulated by redox processes to examine how and why conditions such as prolonged hypoxia, pathological mediators, and other factors promoting vascular remodeling contribute to the development of pulmonary hypertension (PH). Recent Advances and Critical Issues: Aspects of vascular remodeling induction mechanisms described are associated with shifts in glucose metabolism through the pentose phosphate pathway and increased cytosolic NADPH generation by glucose-6-phosphate dehydrogenase, increased glycolysis generation of cytosolic NADH and lactate, mitochondrial dysfunction associated with superoxide dismutase-2 depletion, changes in reactive oxygen species and iron metabolism, and redox signaling. Future Directions: The regulation and impact of hypoxia-inducible factor and the function of cGMP-dependent and redox regulation of protein kinase G are considered for their potential roles as key sensors and coordinators of redox and metabolic processes controlling the progression of vascular pathophysiology in PH, and how modulating aspects of metabolic and redox regulatory systems potentially function in beneficial therapeutic approaches.

Entities:  

Keywords:  guanylate cyclase; hypoxia-inducible factor; metabolic shift; pulmonary hypertension; redox regulation; vascular remodeling

Year:  2018        PMID: 30403147      PMCID: PMC6708269          DOI: 10.1089/ars.2018.7657

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  148 in total

Review 1.  Hypoxic pulmonary vasoconstriction.

Authors:  Rohit Moudgil; Evangelos D Michelakis; Stephen L Archer
Journal:  J Appl Physiol (1985)       Date:  2005-01

2.  Attenuating endoplasmic reticulum stress as a novel therapeutic strategy in pulmonary hypertension.

Authors:  Peter Dromparis; Roxane Paulin; Trevor H Stenson; Alois Haromy; Gopinath Sutendra; Evangelos D Michelakis
Journal:  Circulation       Date:  2012-11-13       Impact factor: 29.690

3.  Redox Mechanisms Influencing cGMP Signaling in Pulmonary Vascular Physiology and Pathophysiology.

Authors:  Dhara Patel; Anand Lakhkar; Michael S Wolin
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

4.  Superoxide activates mitochondrial uncoupling protein 2 from the matrix side. Studies using targeted antioxidants.

Authors:  Karim S Echtay; Michael P Murphy; Robin A J Smith; Darren A Talbot; Martin D Brand
Journal:  J Biol Chem       Date:  2002-10-07       Impact factor: 5.157

Review 5.  Redox modulation of vascular tone: focus of potassium channel mechanisms of dilation.

Authors:  David D Gutterman; Hiroto Miura; Yanping Liu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-02-10       Impact factor: 8.311

6.  Sirtuin 3 deficiency does not augment hypoxia-induced pulmonary hypertension.

Authors:  Gregory B Waypa; Scott W Osborne; Jeremy D Marks; Sara K Berkelhamer; Jyothisri Kondapalli; Paul T Schumacker
Journal:  Am J Respir Cell Mol Biol       Date:  2013-12       Impact factor: 6.914

Review 7.  Targeting HIF-1 for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

8.  Dehydroepiandrosterone promotes pulmonary artery relaxation by NADPH oxidation-elicited subunit dimerization of protein kinase G 1α.

Authors:  Dhara Patel; Sharath Kandhi; Melissa Kelly; Boon Hwa Neo; Michael S Wolin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-12-27       Impact factor: 5.464

9.  Intravenous iron therapy in patients with idiopathic pulmonary arterial hypertension and iron deficiency.

Authors:  Gerrina Ruiter; Emmy Manders; Chris M Happé; Ingrid Schalij; Herman Groepenhoff; Luke S Howard; Martin R Wilkins; Harm J Bogaard; Nico Westerhof; Willem J van der Laarse; Frances S de Man; Anton Vonk-Noordegraaf
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017

10.  THE METABOLISM OF TUMORS IN THE BODY.

Authors:  O Warburg; F Wind; E Negelein
Journal:  J Gen Physiol       Date:  1927-03-07       Impact factor: 4.086

View more
  4 in total

1.  Studies on Hypoxic Pulmonary Vasoconstriction Detect a Novel Role for the Mitochondrial Complex I Subunit Ndufs2 in Controlling Peroxide Generation for Oxygen-Sensing.

Authors:  Michael S Wolin; Norah Alruwaili; Sharath Kandhi
Journal:  Circ Res       Date:  2019-06-06       Impact factor: 17.367

2.  JANEX-1 improves acute pulmonary embolism through VEGF and FAK in pulmonary artery smooth muscle cells.

Authors:  Longfei Pan; Zhuo Peng; Ruipeng Zhang; Rui Zhang; Dean Liang; Heming Chen; Hongyan Tian
Journal:  Exp Biol Med (Maywood)       Date:  2020-07-15

3.  Reciprocal actions of constrictor prostanoids and superoxide in chronic hypoxia-induced pulmonary hypertension: roles of EETs.

Authors:  Sharath Kandhi; Norah Alruwaili; Michael S Wolin; Dong Sun; An Huang
Journal:  Pulm Circ       Date:  2019-12-27       Impact factor: 3.017

4.  Mitochondrial Monoamine Oxidase: Another Player in Pulmonary Hypertension?

Authors:  Natascha Sommer; Rainer Schulz
Journal:  Am J Respir Cell Mol Biol       Date:  2021-03       Impact factor: 6.914

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.